JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


A more recent version of this article appeared on January 18, 2002
This Article
Right arrow Full Text (Accepted Manuscript)
Right arrow All Versions of this Article:
277/4/2517    most recent
M104626200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gusterson, R.
Right arrow Articles by Latchman, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gusterson, R.
Right arrow Articles by Latchman, D.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Papers In Press, published online ahead of print November 8, 2001
J. Biol. Chem, 10.1074/jbc.M104626200
Submitted on May 21, 2001
Revised on November 7, 2001
Accepted on November 8, 2001

The transcriptional co-activators CBP and p300 are activated via Phenylephrine through the p42/p44 MAPK cascade

Rosalind Gusterson, Bhawanjit Brar, David Faulkes, Antonio Giordano, John Chrivia, and David Latchman

Department of Medical Molecular Biology, Institute of Child Health, London WC1N 1EH

Corresponding Author: d.latchman{at}ich.ucl.ac.uk

The CBP and p300 co-activators play a key role in many aspects of gene regulation being recruited to the DNA via transcription factors which are targets for specific signalling pathways. It has previously been demonstrated that in neuronal cells the ability of CBP and p300 to activate transcription can be directly stimulated by NGF or calcium-activated signalling pathways. Here we demonstrate that, in cardiac cells, the activity of CBP and p300 is stimulated by phenylephrine (PE) treatment and that they are required for the activation of ANF gene expression by PE. Activation of CBP/p300 by PE involves the p42/p44 MAPK pathway and targets primarily the N-terminus of p300 and the C-terminus of CBP which are not homologous to one another. To our knowledge, this is the first report of a specific stimulus modulating the activity of CBP and p300 in cardiac cells and suggests that these factors play an important role in the hypertrophic effect of PE.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.